Farkas A - Search Results

1

Effective long-term androgen suppression in men with prostate cancer using a hydrogel implant with the GnRH agonist histrelin.

Schlegel PN, Kuzma P, Frick J, Farkas A, Gomahr A, Spitz I, Chertin B, Mack D, Jungwirth A, King P, Nash H, Bardin CW, Moo-Young A. Schlegel PN, et al. Among authors: farkas a. Urology. 2001 Oct;58(4):578-82. doi: 10.1016/s0090-4295(01)01293-6. Urology. 2001. PMID: 11597543 Clinical Trial.

2

One-stage repair of hypospadias--experience with 856 cases.

Abu-Arafeh W, Chertin B, Zilberman M, Farkas A. Abu-Arafeh W, et al. Among authors: farkas a. Eur Urol. 1998 Oct;34(4):365-7. doi: 10.1159/000019757. Eur Urol. 1998. PMID: 9748687

3

Laser prostatectomy. Long-term follow-up of 303 patients.

Chertin B, Moriel EZ, Hadas-Halperin I, Abu-Arafeh W, Lupa S, Zilberman M, Farkas A. Chertin B, et al. Among authors: farkas a. Eur Urol. 1999 Apr;35(4):285-8. doi: 10.1159/000019862. Eur Urol. 1999. PMID: 10087389

4

Long-acting gonadotropin-releasing hormone implant to maintain medical castration for two years in men with prostate cancer.

Spitz IM, Chertin B, Lindenberg T, Farkas A. Spitz IM, et al. Among authors: farkas a. N Engl J Med. 1999 May 6;340(18):1439. doi: 10.1056/NEJM199905063401814. N Engl J Med. 1999. PMID: 10328706 No abstract available.

5

Does early detection of ureteropelvic junction obstruction improve surgical outcome in terms of renal function?

Chertin B, Fridmans A, Knizhnik M, Hadas-Halperin I, Hain D, Farkas A. Chertin B, et al. Among authors: farkas a. J Urol. 1999 Sep;162(3 Pt 2):1037-40. doi: 10.1016/S0022-5347(01)68058-3. J Urol. 1999. PMID: 10458427

6

An implant releasing the gonadotropin hormone-releasing hormone agonist histrelin maintains medical castration for up to 30 months in metastatic prostate cancer.

Chertin B, Spitz IM, Lindenberg T, Algur N, Zer T, Kuzma P, Young AJ, Catane R, Farkas A. Chertin B, et al. Among authors: farkas a. J Urol. 2000 Mar;163(3):838-44. J Urol. 2000. PMID: 10687989 Clinical Trial.

7

Endoscopic puncture of ureterocele as a minimally invasive and effective long-term procedure in children.

Chertin B, Fridmans A, Hadas-Halpren I, Farkas A. Chertin B, et al. Among authors: farkas a. Eur Urol. 2001 Mar;39(3):332-6. doi: 10.1159/000052463. Eur Urol. 2001. PMID: 11275729

8

1-Stage feminizing genitoplasty: 8 years of experience with 49 cases.

Farkas A, Chertin B, Hadas-Halpren I. Farkas A, et al. J Urol. 2001 Jun;165(6 Pt 2):2341-6. doi: 10.1016/S0022-5347(05)66199-X. J Urol. 2001. PMID: 11371974

9

Feminizing genitoplasty in patients with 46XX congenital adrenal hyperplasia.

Farkas A, Chertin B. Farkas A, et al. J Pediatr Endocrinol Metab. 2001 Jun;14(6):713-22. doi: 10.1515/jpem.2001.14.6.713. J Pediatr Endocrinol Metab. 2001. PMID: 11453519 Review.

10

Tandem CAG repeats of the androgen receptor gene and prostate cancer risk in black and white men.

Panz VR, Joffe BI, Spitz I, Lindenberg T, Farkas A, Haffejee M. Panz VR, et al. Among authors: farkas a. Endocrine. 2001 Jul;15(2):213-6. doi: 10.1385/ENDO:15:2:213. Endocrine. 2001. PMID: 11720249

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

941 results

Search Page

Filters